Search results
Pfizer to Cut Costs in Multi-Year Effort
The Wall Street Journal· 2 days agoPfizer is launching a multi-year cost reduction program expected to include operational efficiencies, network structure changes, and product portfolio...
Free COVID-19 vaccines could be a thing of the past as federal program is set to expire early
Chicago Sun-Times· 2 days agoWhen COVID-19 vaccines entered the commercial market, the federal government introduced a program to...
Bird Flu Cases Spur Retail Trader Rush Into Vaccine Stocks
Bloomberg via Yahoo Finance· 2 days ago(Bloomberg) -- Mounting cases of bird flu in humans is luring the day trading crowd to snap up stock...
Pfizer to Cut Costs in Multi-Year Effort — Update
Morningstar· 2 days agoPfizer is launching a multi-year cost reduction program expected to include operational efficiencies, network structure changes, and product portfolio enhancements. The first ...
3 Stocks That Can Help You to Get Richer in 2025 and Beyond
The Motley Fool via AOL· 11 hours ago(That's no accident, because a falling stock price will boost a dividend yield, and vice versa, and Pfizer's stock was recently down 29% from its 52-week high.) Pfizer ...
The FLiRT COVID variants: What are they and are they more contagious?
Reuters· 11 hours agoThe moniker FLiRT is an acronym for the locations of the mutations the variants share on the virus'...
Moderna, CureVac, other vaccine stocks jump as new human bird-flu cases reported in U.S., Australia
Market Watch· 2 days agoVaccine-related stocks moved sharply higher Wednesday as new human bird-flu cases were reported in...
Here's how U.S. health officials are responding to bird flu in humans after second case
NBC New York· 8 hours agoU.S. health officials have been monitoring and responding to bird flu in humans, even as they stress...
3 Things You Need to Know If You Buy Novavax Today | The Motley Fool
The Motley Fool· 3 days agoNovavax (NVAX 5.30%) stock has both soared and plummeted at times in recent years. Investors...
Better Buy: Inovio Pharmaceuticals vs. Novavax
Motley Fool via Yahoo Finance· 2 days agoThe COVID-19 vaccine was worth tens of billions of dollars, but most of it went into the hands of Moderna and Pfizer. Smaller biotechs that tried to...
